Cullinan Therapeutics, Inc. - COM (CGEM)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
62.9M
Holdings value Q2 2024
$1.1B
Value change Q2 2024
+$412M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
134
Number of buys Q2 2024
12
Number of sells Q2 2024
-5
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 223K $3.74M -$1.4M $16.74 20
2024 Q2 62.9M $1.1B +$412M $17.44 134
2024 Q1 39.4M $671M +$49.2M $17.04 113
2023 Q4 36.9M $376M +$27M $10.19 110
2023 Q3 38M $344M +$11M $9.05 104
2023 Q2 36.7M $395M +$48.7M $10.76 102
2023 Q1 32.2M $329M -$56.3M $10.23 97
2022 Q4 37.7M $398M +$5.32M $10.55 93
2022 Q3 37M $475M -$7.06M $12.82 93
2022 Q2 37.6M $482M +$20.4M $12.82 81
2022 Q1 36.8M $385M +$4.82M $10.47 77
2021 Q4 36.4M $560M +$6.27M $15.43 74
2021 Q3 33.9M $762M +$33.8M $22.57 63
2021 Q2 32.3M $829M -$17.7M $25.75 70
2021 Q1 31.3M $1.3B +$1.3B $41.67 70